Latest news
Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma - Yahoo! Finance CanadaYahoo! Finance Canada · Mon, 10 Aug 2026 06:36:00 GMTInnate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 06:30:00 GMTGuido Oelkers to step down as CEO of Sobi in the beginning of 2027 - Yahoo! Finance CanadaYahoo! Finance Canada · Mon, 03 Aug 2026 05:27:00 GMT